Search Within

Marissa Mattar

Formats
  1. Journal Article (31)
  2. Meeting Abstract (21)
  3. Book Section (3)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. GSK Faculty (52)
  2. Sloan Kettering Institute Postdocs (48)
  3. Department of Pathology and Laboratory Medicine (44)
  4. Human Oncology and Pathogenesis Program (43)
  5. Department of Medicine (42)
  6. Tow Center for Developmental Oncology (TCDO) (40)

More Groups

People
  1. Elisa De Stanchina (44)
  2. Marc Ladanyi (32)
  3. Romel Somwar (31)
  4. Inna Khodos (27)
  5. Alexander Drilon (15)
  6. Charles Rudin (13)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (14)
  5. 2021 (11)
  6. 2020 (8)

More Years

Publications
  1. Cancer Research (6)
  2. Clinical Cancer Research (5)
  3. Journal of Thoracic Oncology (5)
  4. Cancer Discovery (4)
  5. Cancer Cell (3)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. Elsevier Inc. (8)
  3. Cell Press (6)
  4. American Society of Clinical Oncology (5)
  5. Academic Press, Elsevier Inc (3)
  6. Nature Publishing Group (3)

More Publishers

Results (57)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CIC-mediated modulation of MAPK signaling opposes receptor tyrosine kinase inhibitor response in kinase-addicted sarcoma
    Journal Article

    Odintsov, I.; Ortiz, M. V.; Khodos, I.; Mattar, M. S.; Lui, A. J. W.; Kohsaka, S.; de Stanchina, E.; Glade Bender, J. L.; Ladanyi, M.; Somwar, R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling
    Journal Article

    Smith, R. S.; Odintsov, I.; Liu, Z.; Lui, A. J. W.; Hayashi, T.; Vojnic, M.; Suehara, Y.; Delasos, L.; Mattar, M. S.; Hmeljak, J.; more...
    Disease Models & Mechanisms (2022)

    Fulltext@MSK | Save
  • Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer
    Journal Article

    Joshi, S.; Gomes, E. D.; Wang, T.; Corben, A.; Taldone, T.; Gandu, S.; Xu, C.; Sharma, S.; Buddaseth, S.; Yan, P.; more...
    Communications Biology (2021)

    Fulltext@MSK | Save
  • Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
    Journal Article

    Chan, J. M.; Quintanal-Villalonga, Á; Gao, V. R.; Xie, Y.; Allaj, V.; Chaudhary, O.; Masilionis, I.; Egger, J.; Chow, A.; Walle, T.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • The HER2xHER3 bi-specific antibody Zenocutuzumab is effective at blocking growth of tumors driven by NRG1 gene fusions
    Meeting Abstract

    Odintsov, I.; Khodos, I.; Espinosa-Cotton, M.; Lui, A. J.; Mattar, M.; Schram, A. M.; Schackmann, R. C.; Lammerts van Bueren, J.; Geuijen, C. A.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Temporal modulation of antigen availability to improve antibody-tumor binding and therapeutic efficacy
    Meeting Abstract

    Pereira, P.; Mandleywala, K.; Ragupathi, A.; Mattar, M.; Monette, S.; Janjigian, Y.; Lewis, J.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Novel preclinical patient-derived lung cancer models reveal inhibition of HER3 and MTOR signaling as therapeutic strategies for NRG1 fusion-positive cancers
    Journal Article

    Odintsov, I.; Mattar, M. S.; Lui, A. J. W.; Offin, M.; Kurzatkowski, C.; Delasos, L.; Khodos, I.; Asher, M.; Daly, R. M.; Rekhtman, N.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity
    Journal Article

    Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • The anti-HER3 mAb seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with oncogenic NRG1 fusions
    Journal Article

    Odintsov, I.; Lui, A. J. W.; Sisso, W. J.; Gladstone, E.; Liu, Z.; Delasos, L.; Kurth, R. I.; Sisso, E. M.; Vojnic, M.; Khodos, I.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Genomic characterization of a comprehensive collection of esophagogastric cancer patient-derived xenografts
    Meeting Abstract

    Moy, R. H.; Mattar, M.; Molena, D.; Strong, V. E.; Jones, D. R.; Coit, D. G.; Tang, L.; Maron, S. B.; Hechtman, J. F.; de Stanchina, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save